Higher PD-L1 expression and TMB value were considered to imply a favorable efficacy of immunotherapy (Gibney et al., 2016), and in this study, we discovered DMS was negatively correlated to TMB and PD-L1 expression in colon cancer, which validated the predictive value of DMS indirectly. Here, CD274 is linked to malignant colon neoplasm.